Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Arrowhead Pharmaceuticals Inc. buy Quitte

Arrowhead Pharmaceuticals Inc.
Start price
€5.54
07.12.15 / 50%
Target price
€6.40
07.06.16
Performance (%)
0.59%
End price
€5.57
07.06.16
Summary
This prediction ended on 07.06.16 with a price of €5.57. The BUY prediction by Quitte for Arrowhead Pharmaceuticals Inc. closed nearly unchanged. Quitte has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Arrowhead Pharmaceuticals Inc. -1.187% -1.187% 327.504% 178.306%
iShares Core DAX® 0,44 % 5,90 % 8,05 % 65,58 %
iShares Nasdaq 100 1,06 % 0,92 % 28,47 % 90,18 %
iShares Nikkei 225® 1,77 % 1,23 % 47,57 % 84,99 %
iShares S&P 500 0,37 % 1,92 % 23,20 % 70,76 %

Comments by Quitte for this prediction

In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) 0.59%
Target price 6.404
Change
Ends at 07.06.16

mich laust der Affe

       was dem Affen nützt .... 

Arrowhead’s ARC-520 Leads to Consistent Immune Reactivation in Chimpanzees with Chronic Hepatitis B Infection

By Business Wire,  December 07, 2015, 07:30:00 AM EDT



Read more: http://www.nasdaq.com/press-release/arrowheads-arc-520-leads-to-consistent-immune-reactivation-in-chimpanzees-with-chronic-hepatitis-b-20151207-00217#ixzz3teYapJIP

View source version on businesswire.com: http://www.businesswire.com/news/home/20151207005427/en/        

Quitte 
0
Report Share
07.12.15
Prediction Buy
Perf. (%) 0.59%
Target price 6.404
Change
Ends at 07.06.16

(Laufzeit überschritten)

Quitte 
0
Report Share
07.06.16

Stopped prediction by Quitte for Arrowhead Pharmaceuticals Inc.

buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.71
07.08.17
€18.04
06.09.18
954.21%
06.09.18

Quitte 
21.08.19 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€2.21
09.01.17
€2.40
30.06.17
-38.38%
30.06.17

Quitte 
21.08.19 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.34
01.12.16
€1.40
01.12.16
-6.39%
01.12.16

Quitte 
21.08.19 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.58
11.09.15
€6.10
16.09.15
10.19%
16.09.15

Quitte 
21.08.19 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.54
04.08.15
€5.80
05.08.15
7.76%
05.08.15

Quitte 
21.08.19 50%
buy
Arrowhead Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.02.15
€6.20
03.08.15
0.34%
03.08.15

Quitte 
21.08.19 50%